Berkshire Hathaway Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Berkshire Hathaway Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1402
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:198
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Berkshire Hathaway Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Berkshire Hathaway Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Berkshire Hathaway Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Berkshire Hathaway Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Berkshire Hathaway Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Berkshire Hathaway Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Berkshire Hathaway Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Berkshire Hathaway Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Berkshire Hathaway Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 129
Corporate Venturing – Overview 129
Corporate Venturing – Deal reports 130
DIVESTMENTS 153
Divestments – Overview 153
Divestments – Deal reports 154
APPENDIX 188
Contact Us 188
About MarketLine Financial Deals Database 188
Deal Definition and Methodology 190
About MarketLine 197

List of Tables
Table 1: Berkshire Hathaway Inc. M&A volume and value trend (2014-YTD2018)
Table 2: Berkshire Hathaway Inc. M&A activity by geography (2014-YTD2018)
Table 3: Berkshire Hathaway Inc. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Berkshire Hathaway Inc. corporate venturing by geography (2014-YTD2018)
Table 5: Berkshire Hathaway Inc. divestments volume and value trend (2014-YTD2018)
Table 6: Berkshire Hathaway Inc. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Berkshire Hathaway Inc. M&A volume and value trend (2014-YTD2018)
Figure 2: Berkshire Hathaway Inc. M&A activity by geography (2014-YTD2018)
Figure 3: Berkshire Hathaway Inc. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Berkshire Hathaway Inc. corporate venturing by geography (2014-YTD2018)
Figure 5: Berkshire Hathaway Inc. divestments volume and value trend (2014-YTD2018)
Figure 6: Berkshire Hathaway Inc. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Berkshire Hathaway Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Interstate Hotels & Resorts Inc:企業の戦略・SWOT・財務情報
    Interstate Hotels & Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Interstate Hotels & Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • RPC Group PLC:企業のM&A・事業提携・投資動向
    RPC Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RPC Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • National Bank Of Kuwait Sak:企業の戦略・SWOT・財務分析
    National Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Trex Company Inc (TREX):企業の財務・戦略的SWOT分析
    Trex Company Inc (TREX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Meiji Seika Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Meiji Seika Pharma Co Ltd (Meiji Seika Pharma), a subsidiary of Meiji Holdings Co Ltd, is a pharmaceutical solutions provider that carries out manufacturing and sale of ethical pharmaceuticals, agricultural chemicals and veterinary drugs. The company provides Streptomycin Meiji, Kanamycin Me …
  • Winbond Electronics Corporation (2344):企業の財務・戦略的SWOT分析
    Winbond Electronics Corporation (2344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Veracyte Inc (VCYT):医療機器:M&Aディール及び事業提携情報
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • Biosensors International Group Ltd:企業の戦略的SWOT分析
    Biosensors International Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • NGL Energy Partners LP:企業の戦略・SWOT・財務情報
    NGL Energy Partners LP - Strategy, SWOT and Corporate Finance Report Summary NGL Energy Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oncolys BioPharma Inc (4588):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers and develops treatments for cancer and infectious diseases. The company import and export products including drugs and medicines, oncolytic viruses, pharmaceutical pipeline products and tumor diagnostic agents, among o …
  • Green Cross Holdings Corp (005250):企業の財務・戦略的SWOT分析
    Summary Green Cross Holdings Corp (Green Cross) is a developer and manufacturer of pediatric and adult vaccines against infectious diseases. The company’s products comprise specialty medicines, general medicines, health functional foods, products for infants and toddlers, cosmetics, quasi drugs and …
  • Ascendis Pharma AS (ASND):製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Ziehm Imaging GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that develops, produce and markets mobile X-ray based imaging solutions. The company's products include c-arms with flat panel detectors, c-arms with 3D imaging and c-arms with image intensifier. It offers Ziehm Vision RFD 3D, 3D …
  • Ardena Holding NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Ardena Holding NV (Ardena) is a contract development and manufacturing organization. The company offers solid-state chemistry services including polymorph, salt, and co-crystal screening; bio-analytical and formulation development; early-phase clinical supply manufacturing; clinical logistic …
  • PT Aerowisata:企業の戦略・SWOT・財務分析
    PT Aerowisata - Strategy, SWOT and Corporate Finance Report Summary PT Aerowisata - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Punjab National Bank:戦略・SWOT・企業財務分析
    Punjab National Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆